This American Academy of Ophthalmology collection of activities provides ophthalmologists with a focused update on the latest data surrounding long-acting intravitreal anti-vascular endothelial growth factor (VEGF) therapies for neovascular age-related macular degeneration (nAMD).
Macular Degeneration
Archived
Extending Treatment Durability With Next-Generation nAMD Therapies
Webinar
Credit Hours: 0.50 (30 min)
This activity has expired and is no longer available for credit
Advances in Imaging nAMD and Approaches to Use of Long-Acting Anti-VEGF Therapies
Infographic
Credit Hours: 0.50 (30 min)
This activity has expired and is no longer available for credit
Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD
Case Consult
Credit Hours: 0.25 (15 min)
This activity has expired and is no longer available for credit
When to Start, When to Switch, and Dosing Strategy With Anti-VEGF Therapy
Case Consult
Credit Hours: 0.25 (15 min)
This activity has expired and is no longer available for credit
Success With Extended Dosing Intervals of Anti-VEGF Therapies for nAMD
Case Consult
Credit Hours: 0.25 (15 min)
This activity has expired and is no longer available for credit
Strategies to Reduce Vision Loss in nAMD Using Long-Acting Anti-VEGF Therapies
Patient Simulation
Credit Hours: 0.50 (30 min)
This activity has expired and is no longer available for credit